The National Agency for Food and Drug Administration and Control, NAFDAC, has dismissed claims circulating about a purported secret ban on amoxicillin.
In a statement by NAFDAC Director-General Prof. Moji Shola Adeyeye, she said that the agency has neither secretly nor openly planned a ban on amoxicillin.
This was in response to a viral social media post claiming that NAFDAC had banned the antibiotic.
Reacting, NAFDAC described the claim as false and devoid of any factual basis.
“NAFDAC has not banned amoxicillin in Nigeria, either secretly or openly,” the regulatory agency said in a statement on Monday.
It clarified that the agency publicly notifies Nigerians of any regulatory actions through official channels.
“In recent months, NAFDAC issued targeted safety alerts on certain brands and batches of amoxicillin. In August 2025, Public Alert No. 24/2025 announced the recall of Amoxivue (Amoxicillin) 500 mg capsules due to low Active Pharmaceutical Ingredient (API) content. In October 2025, Public Alert No. 34/2025 addressed substandard batches of Astamocil and Astamentin suspensions, while Public Alert No. 35/2025 notified the public of substandard batches of Annmox and Jawamox suspensions. These actions were specific to identified products and do not constitute a ban on amoxicillin,” NAFDAC added.
